The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-comparison analysis of bendamustine, rituximab, etoposide and carboplatin (TREC) vs. RICE/R-DHAP in relapsed lymphoma.
 
Anneliese M Bodding-Long
No Relationships to Disclose
 
L. Elizabeth Budde
Research Funding - Cell Medica (Inst); Gilead Sciences (Inst); Seagen (Inst)
 
Jennifer E Roden
No Relationships to Disclose
 
Ajay K. Gopal
Honoraria - Millennium; Seagen; Takeda
Consulting or Advisory Role - Gilead Sciences; Janssen; Pfizer; Seagen
Speakers' Bureau - Janssen; Millennium; Seagen; Takeda
Research Funding - Abbott Biotherapeutics (Inst); Biogen (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Pfizer (Inst); Piramal Life Science (Inst); Seagen (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Teva (Inst)
 
Tara L Chen
No Relationships to Disclose